Underrepresented Minority Fellowship in Gene and Cell Therapy for Oncology
The American Society for Gene + Cell Therapy (ASGCT) will award $100,000 to a postdoctoral or early-career oncology researcher from a racial or ethnic minority group underrepresented in the scientific workforce.
Racial and ethnic minorities are underrepresented in the scientific workforce, specifically in the number of postdoctoral fellows transitioning into faculty positions. ASGCT is committed to addressing these disparities and providing opportunities for professional development in biomedical research for underrepresented groups. Therefore, the Society is initiating this $100,000 award to support one ASGCT member in a postdoctoral or early-stage investigator fellowship in gene or cell therapy-related research for an oncology indication for one year (November 2023 to December 2024).
This award is supported by grants funding provided by Bristol-Myers Squibb.
One year.
Winners will be notified by November 15 and awards will be processed by November 30.
Up to $100,000
Applicants must:
- Self-identify as Black, Indigenous, and/or Latinx.
- Be a member of ASGCT. Not an ASGCT member yet? Take the first step. Submit your membership application at least 5 business days prior to the application deadline to allow sufficient time for processing.
- Have a research focus on gene and cell therapy for oncology indications.
- Be a U.S. citizen or have been lawfully admitted for permanent residence.
- Be a postdoctoral or early-stage investigator.
- Have clear and documented support of an established mentor who has active noncommercial funding and will remain funded for the duration of the award term, or who is recognized through national clinical leadership (if the project is clinical).
- Provide documentation from an institutional leader with the authority to ensure that at least 75 percent of the applicant’s full-time professional efforts will be devoted to research during the funded period.
- Website